Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine, progesterone, and magnesium sulfate for severe head injury
IRCT201210229534N2Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of nimodipine, progesterone and magnesium sulfate in traumatic brain injury (TBI), sponsored by Hamadan University of Medical Sciences. Started Mar 2012; status: completed.
02
Drugs
nimodipineprogesteronemagnesium sulfate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT201210229534N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201210229534N2.